Therapeutic insights from genomic studies of head and neck squamous cell carcinomas
about
HPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment StrategiesFibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review.Canine spontaneous head and neck squamous cell carcinomas represent their human counterparts at the molecular levelBiomarker and Tumor Responses of Oral Cavity Squamous Cell Carcinoma to Trametinib: A Phase II Neoadjuvant Window-of-Opportunity Clinical Trial.Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.Fibroblast growth factor receptor 3 protein is overexpressed in oral and oropharyngeal squamous cell carcinoma.The head and neck cancer immune landscape and its immunotherapeutic implications.Identification of new candidate therapeutic target genes in head and neck squamous cell carcinomas.Targeting pathways mediating resistance to anti-EGFR therapy in squamous cell carcinoma of the head and neck.Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas.EGFR-targeted therapies in the post-genomic era.A wound-healing program is hijacked to promote cancer metastasis.Genomic insights into head and neck cancer.Evaluation of Prexasertib, a Checkpoint Kinase 1 Inhibitor, in a Phase Ib Study of Patients with Squamous Cell Carcinoma.
P2860
Q26752584-23EA6608-2DF1-4425-A647-7CE2980ABA61Q27853178-54F746A8-58CE-431C-B81C-240AD5C56499Q28547714-4080905F-5483-4A32-BEE2-E42A84E2669FQ33902520-2CBA435C-6C97-408C-840C-79A56C662B9CQ36203560-0205C1B8-24E1-4424-91FF-7FA25E0F264BQ36528389-00EDF63F-DEAC-401F-BF53-99826BBBEC1EQ37351606-01865AD6-44D6-41C8-9BAD-09532ACBC40BQ37565157-0061E0E5-58F1-4578-9570-2ECAEF5A6924Q38892486-920D0C97-A175-464C-909B-EFDE4BBB475BQ39031921-B9A98532-578E-48B1-83F5-8C5B255D069BQ45871491-5430FC84-8589-4B2F-858F-EDDB92044CA0Q50113785-980550D1-0CBD-4C25-9A8F-2EDB7CDD36DAQ50917827-48E7FE2B-9DDD-43E2-AC41-6C4542D6FE59Q54116465-B0A23CD9-C0E8-4A00-BF60-27B85B1FDBE3
P2860
Therapeutic insights from genomic studies of head and neck squamous cell carcinomas
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Therapeutic insights from genomic studies of head and neck squamous cell carcinomas
@ast
Therapeutic insights from genomic studies of head and neck squamous cell carcinomas
@en
Therapeutic insights from genomic studies of head and neck squamous cell carcinomas
@nl
type
label
Therapeutic insights from genomic studies of head and neck squamous cell carcinomas
@ast
Therapeutic insights from genomic studies of head and neck squamous cell carcinomas
@en
Therapeutic insights from genomic studies of head and neck squamous cell carcinomas
@nl
prefLabel
Therapeutic insights from genomic studies of head and neck squamous cell carcinomas
@ast
Therapeutic insights from genomic studies of head and neck squamous cell carcinomas
@en
Therapeutic insights from genomic studies of head and neck squamous cell carcinomas
@nl
P2093
P2860
P3181
P1433
P1476
Therapeutic insights from genomic studies of head and neck squamous cell carcinomas
@en
P2093
D. N. Hayes
J. R. Grandis
P. S. Hammerman
P2860
P304
P3181
P356
10.1158/2159-8290.CD-14-1205
P407
P577
2015-03-01T00:00:00Z